Elsevier announces iCONSULT to be offered as part of Epic electronic health record

Partnership puts FIRST Consult and other evidence-based clinical information directly into electronic health record service for hospitals and medical practices

January 20, 2006 – Elsevier, a world-leading medical publisher, today announced a strategic partnership to deliver Elsevier’s iCONSULT service directly to the hospital and group medical practice community as part of Epic Systems Corporation’s electronic health record. iCONSULT delivers real-time clinical decision support by putting evidence-based, point-of-care clinical reference content directly into the electronic workflow of health practitioners. The combination of these offerings enhances solutions that help healthcare providers support best practices and reduce healthcare costs.

“This partnership of a world-class content provider with an industry-leading EHR vendor is exactly what healthcare organizations need for their medical staff,” says Charles Safran, M.D., Associate Clinical Professor of Medicine, Harvard Medical School and iCONSULT Advisory Board member. “iCONSULT’s ability to deliver concise, evidence-based information directly into the electronic health record can help reduce errors and drive EHR adoption in today’s rapidly evolving healthcare environment.”

Elsevier, a world-leading science and medical publisher, developed iCONSULT to integrate its clinical reference content directly into the electronic workflow and enhance clinical decision support. Content is indexed against industry standard clinical vocabularies, patient demographics and organized around the clinician’s workflow, allowing iCONSULT to deliver rapid answers to specific patient scenarios directly into the electronic health record. Products offered via the iCONSULT service include:

  • FIRST Consult, Elsevier’s premier point of care, evidence based medical reference tool, indexed by ICD9-CM codes, and updated weekly to offer information on evaluation, diagnosis and treatment of a variety of disease categories.
  • MD Consult, the leading industry medical reference database, allowing users to seamlessly search and access clinical information.

"This partnership is an absolute victory for health practitioners and will change the way they consume medical information to support their clinical decisions. Valuable partnerships like this are very important to our overall strategy of putting more and more relevant clinical information directly at the point of care," says Brian Nairn, CEO, Elsevier, Health Science Division.

Elsevier is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc , a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange). 

About Elsevier
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com

Media Contact:
Mike Smith, Elsevier 
+1 314 453 5070